Author Title [ Type(Desc)] Year
Filters: Keyword is Humans  [Clear All Filters]
Journal Article
Liantonio A, Accardi A, Carbonara G, Fracchiolla G, Loiodice F, Tortorella P, Traverso S, Guida P, Pierno S, De Luca A et al..  2002.  Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid.. Mol Pharmacol. 62(2):265-71.
Liantonio A, Picollo A, Carbonara G, Fracchiolla G, Tortorella P, Loiodice F, Laghezza A, Babini E, Zifarelli G, Pusch M et al..  2008.  Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands.. Proc Natl Acad Sci U S A. 105(4):1369-73.
Ali HH, Savarese JJ.  1976.  Monitoring of neuromuscular function.. Anesthesiology. 45(2):216-49.
Perry NW, McCoy JG, Cunningham WR, Falgout JC, Street WJ.  1976.  Multivariate visual evoked response correlates of intelligence.. Psychophysiology. 13(4):323-9.
Mitchell MM, Ali HH, Savarese JJ.  1978.  Myotonia and neuromuscular blocking agents.. Anesthesiology. 49(1):44-8.
Savarese JJ, Lowenstein E.  1985.  The name of the game: no anesthesia by cookbook.. Anesthesiology. 62(6):703-5.
Pryor KO, Hemmings HC.  2014.  NAP5: intraoperative awareness detected, and undetected.. Br J Anaesth. 113(4):530-3.
Lien CA, Belmont MR, Abalos A, Hass D, Savarese JJ.  1999.  The nature of spontaneous recovery from mivacurium-induced neuromuscular block.. Anesth Analg. 88(3):648-53.
Ryan TA.  2001.  NCAM and vesicle cycling: the importance of good glue in the long run.. Neuron. 32(5):759-61.
Lien CA.  2012.  A need to establish programs to detect and prevent drug diversion.. Mayo Clin Proc. 87(7):607-9.
Lien CA.  2010.  Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent? Anesthesiology. 112(1):16-8.
Pamnani A, Rosenstein M, Darwich A, Wolfson A.  2010.  Neuraxial anesthesia for labor and cesarean delivery in a parturient with hereditary antithrombin deficiency on recombinant human antithrombin infusion therapy.. J Clin Anesth. 22(6):450-3.
Hung JC, Azam N, Puttanniah V, Malhotra V, Gulati A.  2014.  Neurolytic transversus abdominal plane block with alcohol for long-term malignancy related pain control.. Pain Physician. 17(6):E755-60.
Goudsouzian NG, Alifimoff JK, Liu LM, Foster V, McNulty B, Savarese JJ.  1989.  Neuromuscular and cardiovascular effects of doxacurium in children anaesthetized with halothane.. Br J Anaesth. 62(3):263-8.
Goudsouzian NG, Alifimoff JK, Eberly C, Smeets R, Griswold J, Miler V, McNulty BF, Savarese JJ.  1989.  Neuromuscular and cardiovascular effects of mivacurium in children.. Anesthesiology. 70(2):237-42.
Boros EE, Samano V, Ray JA, Thompson JB, Jung DK, Kaldor I, Koble CS, Martin MT, Styles VL, Mook RA et al..  2003.  Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeys.. J Med Chem. 46(12):2502-15.
Kopman AF, Lien CA, Naguib M.  2011.  Neuromuscular dose-response studies: determining sample size.. Br J Anaesth. 106(2):194-8.
Goudsouzian NG, Ryan JF, Savarese JJ.  1974.  The neuromuscular effects of pancuronium in infants and children.. Anesthesiology. 41(1):95-8.
Hemmings HC.  2004.  Neuroprotection by Na+ channel blockade.. J Neurosurg Anesthesiol. 16(1):100-1.
Grobelny BT, Rubin D, Fleischut P, Rubens E, Mack PFogarty, Fink M, Placantonakis DG, Elowitz EH.  2012.  Neurosurgical management of symptomatic thoracic spinal ossification in a patient with fibrodysplasia ossificans progressiva.. J Neurosurg Spine. 16(3):285-8.
Perouansky M, Hemmings HC.  2009.  Neurotoxicity of general anesthetics: cause for concern? Anesthesiology. 111(6):1365-71.
Donlon JV, Ali HH, Savarese JJ.  1974.  A new approach to the study of four nondepolarizing relaxants in man.. Anesth Analg. 53(6):934-9.
Savarese JJ.  1981.  The new neuromuscular blocking drugs are here.. Anesthesiology. 55(1):1-3.
Eger EI, Raines DE, Shafer SL, Hemmings HC, Sonner JM.  2008.  Is a new paradigm needed to explain how inhaled anesthetics produce immobility? Anesth Analg. 107(3):832-48.
Neumann S, Eliseeva E, McCoy JG, Napolitano G, Giuliani C, Monaco F, Huang W, Gershengorn MC.  2011.  A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor.. J Clin Endocrinol Metab. 96(2):548-54.